Search results for: Adrian Towse
Filter search results
OHE at ISPOR Italy Chapter – Rome: Are Wider Societal Effects Considered in Healthcare Decision-making?
17 May 2016
…work: Garau, M., Shah, K.K., Sharma, P. and Towse, A., 2016. Is the Link Between Health and Wealth Considered in Decision Making? Results from a Qualitative Study. International Journal of…
Contract Theory: Nobel Offerings to Health Economics
11 October 2016
…performance of the product in a defined patient population over a defined time period, so that reimbursement is based on the health and cost outcomes achieved (Garrison, Towse et al.,…
Recently Published: Reports on Policy Options for Formulary Development in Middle-income Countries and A Case Study from Mexico
4 January 2017
…process. Download the full reports here: Policy Options for Formulary Development in Middle-income Countries Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study A related publication is: Towse,…
A Critique of Hill et al. (2018) on Estimated Costs of Production for the WHO Essential Medicines List
19 May 2018
…have prices three times above the estimated price. The OHE Report is funded by the IFPMA and co-authored by Adrian Towse, Karla Hernandez-Villafuerte and Brendan Shaw. Read the…
NICE Recommendation Highlights Role of Social Value Judgements
9 August 2018
…A review of the literature. Health Policy, 93(2-3), pp.77-84. DOI | RePEc Towse, A. and Garau, M., 2018. Appraising ultra-orphan drugs: is cost-per QALY appropriate? A review of the evidence….
MoCA Initiative and its Value Framework: An Opportunity to Improve Decision Making for Orphan Drugs in Europe?
18 September 2018
…product will reach the market at all. Towse, A. and Garau, M. (2018). Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence. OHE Consulting Report. RePEc Zamora, B.,…
Public Preferences for Health Gains and Cures: A Discrete Choice Experiment
22 January 2019
…Report, London: Office of Health Economics Karlsberg-Schaffer, S., Messner, D., Mestre-Ferrandiz, J., Tambor, E. and Towse, A., 2018. Paying for Cures: Perspectives on Solutions to the “Affordability Issue”. Value in…
OHE Response to Public Consultation on NICE Principles
7 February 2019
…pp.145-165. DOI. RePEc. Shah, K.K., 2017. Valuing Health at the End of Life. PhD thesis. Sheffield: University of Sheffield. Towse, A. and Garau, M., 2018. Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY…
The World Needs Better Drugs for TB. The Center for Global Development and OHE Have a Proposal and We Need your Feedback
5 March 2019
…Development. This blog post has also been published on the Center for Global Development website. Chalkidou, K., Garau, M., Nemzoff,C., Rodes-Sanchez, M., Silverman, R., and Towse A. (2019). Blueprint for…